Physician profile
Patrick J Flaherty
NPI 1740273184
$4,643.42
in general payments reported to CMS, 2019-2025
16 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $16.76 · 2021: $126 · 2022: $188 · 2023: $2,260 · 2024: $884 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Travel and Lodging: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.92 |
| Travel and Lodging | $1,214.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,922.27 | 2019-2025 | Optis, Diamondback Coronary, Coroflow |
| Shockwave Medical, INC | $452.07 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $324.87 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $276.08 | 2019-2022 | |
| Opsens INC. | $180.04 | 2019 | |
| Biotronik INC. | $129.93 | 2022 | |
| Boston Scientific Corporation | $119.78 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $69.79 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $49.70 | 2024-2025 | Wegovy |
| Inari Medical, INC. | $28.19 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.73 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 2022 | |
| Cordis US Corp. | $15.81 | 2024 | Rain Sheath |
| Merck Sharp & Dohme LLC | $14.07 | 2025 | Verquvo |
| Amgen INC. | $13.62 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $3.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.